Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H24O5 |
Molecular Weight | 284.3481 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@H](O)[C@@H]2C)O4
InChI
InChIKey=BJDCWCLMFKKGEE-ISOSDAIHSA-N
InChI=1S/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-,10+,11+,12+,13-,14-,15-/m1/s1
Molecular Formula | C15H24O5 |
Molecular Weight | 284.3481 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:30:17 UTC 2023
by
admin
on
Sat Dec 16 16:30:17 UTC 2023
|
Record UNII |
6A9O50735X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
P01BF05
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
||
|
NCI_THESAURUS |
C271
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
||
|
WHO-ATC |
P01BE05
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
234006
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/07/468
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EURARTESIM (AUTHORIZED: MALARIA)
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB30709
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
100000115442
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
C039060
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
DB11638
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
DTXSID501021652
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
6A9O50735X
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
71939-50-9
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
3000518
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
ARTENIMOL
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | Description: Colourless needles or a white or almost white, crystalline powder. Solubility: Practically insoluble in water; slightly soluble in acetonitrile R, ethanol (~750 g/l) TS and dichloromethane R. Category: Antimalarial. Storage: Artenimol should be kept in a well-closed container, protected from light. Definition: Artenimol contains not less than 97.0% and not more than the equivalent of 102.0% of C15H24O5 using Assay method A, and not less than 98.0% and not more than the equivalent of 102.0% of C15H24O5 using Assay method B, both calculated with reference to the dried substance. | ||
|
1200520
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
7777
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
DIHYDROARTEMISININ
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
m2077
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | Merck Index | ||
|
4194
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
C87432
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY | |||
|
CHEMBL252518
Created by
admin on Sat Dec 16 16:30:19 UTC 2023 , Edited by admin on Sat Dec 16 16:30:19 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
PARENT -> DERIVATIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PARENT -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
PARENT -> IMPURITY |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|